| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05eb2aaeeed4b295099017b5f609f073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bf21394b36192843fb181f46b91348c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c98b1513e8f9e30e2ec40a27e62a0240
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3dbf114df57ead2a0160281fb43d7bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08a4b37b3ee7bf37a7870d69a8dc776c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2021-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eafec2fee44773f2a70831c39e752fd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a70e06135c771ef84a620a5a413d3ae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5513d6fb51044c6f89f6ed0b4b2404b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_549a1228788860db04069b209c77ee91 |
| publicationDate |
2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021198329-A1 |
| titleOfInvention |
Peptides for targeting lrp6-overexpressed cells |
| abstract |
A composition for targeting low-density lipoprotein receptor-related protein 6 (LRP6)-overexpressed cells. The composition includes a peptide including at least one of SEQ ID NO: 1 and SEQ ID NO: 3. |
| priorityDate |
2020-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |